RVV
COM:REVIVETHERA
Revive Therapeutics Ltd.
- Stock
Last Close
0.01
22/11 20:58
Market Cap
3.58M
Beta: -
Volume Today
45K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 0.00 - | |||||||||||
average payables | 144.04K - | 393.16K 172.96% | 367.73K 6.47% | 225.18K 38.76% | 206.40K 8.34% | 204.83K 0.76% | 323.02K 57.70% | 2.18M 573.64% | 3.29M 51.16% | 2.62M 20.30% | ||
average receivables | 30.77K - | 53.92K 75.22% | 23.15K 57.07% | 1.23K 94.70% | 1.23K 0% | 88.78K - | 152.17K 71.41% | 158.95K 4.45% | 174.08K 9.52% | 89.00K 48.87% | ||
book value per share | 0.06 - | 0.11 76.84% | 0.02 78.59% | 0.03 44.36% | 0.01 56.61% | 0.02 2.20% | 0.07 362.80% | 0.11 54.93% | 0.04 63.40% | 0.03 20.36% | 0.02 39.45% | |
capex per share | -0.00 - | -0.00 13.13% | -0.00 96.49% | -0.00 48.67% | -0.00 514.23% | -0.00 94.51% | -0.01 - | |||||
capex to depreciation | -7.32 - | -5.76 21.21% | -0.24 95.82% | -0.42 75.99% | -3.48 720.77% | -0.21 93.85% | -3.87K - | |||||
capex to operating cash flow | 0.04 - | 0.03 38.53% | 0.00 97.03% | 0.00 3.59% | 0.01 899.58% | 0.00 92.06% | 0.36 - | |||||
capex to revenue | ||||||||||||
cash per share | 0.06 - | 0.12 98.52% | 0.06 52.43% | 0.04 32.58% | 0.02 48.82% | 0.01 60.86% | 0.01 86.58% | 0.06 347.69% | 0.01 80.27% | 0.01 49.77% | 0.00 64.83% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 2.87M - | |||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.06 - | 0.01 75.26% | 0.02 37.65% | 0.02 19.73% | 0.00 84.62% | |||||||
debt to equity | 0.06 - | 0.01 76.98% | 0.03 80.15% | 0.02 20.69% | 0.00 83.09% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.16 - | -0.21 26.64% | -1.19 475.00% | -0.16 86.43% | -0.15 6.69% | -0.23 49.86% | -0.14 39.00% | -0.13 7.02% | -0.12 5.27% | -0.41 241.38% | -1.48 256.78% | |
enterprise value | 6.51M - | 7.33M 12.60% | 969.23K 86.78% | 8.25M 750.75% | 10.11M 22.66% | 5.60M 44.61% | 30.08M 436.94% | 141.64M 370.88% | 143.50M 1.32% | 13.40M 90.66% | 3.01M 77.57% | |
enterprise value over ebitda | -11.73 - | -3.68 68.65% | -0.37 90.05% | -4.77 1,203.28% | -5.34 12.07% | -4.27 20.15% | -6.25 46.51% | -7.66 22.54% | -8.10 5.77% | -2.48 69.42% | -0.54 78.30% | |
ev to operating cash flow | -8.47 - | -4.91 42.05% | -0.49 90.06% | -3.96 712.05% | -6.75 70.37% | -4.73 29.96% | -11.96 152.92% | -17.05 42.60% | -10.99 35.56% | -2.22 79.75% | -0.91 58.92% | |
ev to sales | ||||||||||||
free cash flow per share | -0.04 - | -0.07 81.22% | -0.08 15.45% | -0.04 46.76% | -0.03 38.15% | -0.02 31.39% | -0.02 26.99% | -0.04 79.59% | -0.04 3.37% | -0.02 56.53% | -0.01 51.29% | |
free cash flow yield | -0.10 - | -0.16 49.98% | -0.86 453.79% | -0.21 75.91% | -0.14 35.06% | -0.20 44.44% | -0.08 58.40% | -0.07 11.73% | -0.09 23.93% | -0.39 344.38% | -0.86 119.20% | |
graham net net | 0.06 - | 0.10 81.87% | 0.02 79.40% | 0.03 44.34% | 0.01 55.56% | 0.00 82.39% | 0.01 205.42% | 0.06 700.80% | -0.00 102.15% | -0.00 225.32% | -0.01 64.14% | |
graham number | 0.29 - | 0.48 64.50% | 0.24 49.34% | 0.16 34.20% | 0.10 37.90% | 0.09 14.71% | 0.25 193.56% | 0.43 71.19% | 0.22 48.01% | 0.11 48.43% | 0.08 30.71% | |
income quality | 0.61 - | 0.74 20.27% | 0.73 1.31% | 1.29 77.51% | 0.84 35.04% | 0.88 5.38% | 0.47 46.99% | 0.41 11.67% | 0.73 77.64% | 0.95 29.97% | 0.59 38.56% | |
intangibles to total assets | 0.04 - | 0.03 32.93% | 0.02 24.60% | 0.01 49.21% | 0.03 136.41% | 0 100% | 0.67 Infinity% | 0.42 37.01% | 0.73 74.66% | 0.82 12.30% | 0.88 7.20% | |
interest coverage | -2.57K - | 920.14 135.78% | -696.71 175.72% | -55.23 - | -234.18 324.00% | -279.34 19.29% | -123.02 55.96% | -141.10 14.70% | ||||
interest debt per share | 0.00 - | -0.00 188.23% | 0.00 227.58% | 0.01 - | 0.00 64.28% | 0.00 33.87% | 0.00 36.48% | 0.00 83.59% | ||||
inventory turnover | ||||||||||||
invested capital | 0.06 - | 0.01 76.98% | 0.03 80.15% | 0.02 20.69% | 7.20M 34,892,260,566.20% | |||||||
market cap | 7.70M - | 9.82M 27.58% | 2.30M 76.56% | 10.01M 334.94% | 11.17M 11.59% | 6.08M 45.62% | 30.99M 410.02% | 157.82M 409.19% | 147.09M 6.80% | 15.27M 89.62% | 3.80M 75.09% | |
net current asset value | 1.20M - | 2.28M 90.19% | 531.80K 76.67% | 1.59M 198.76% | 786.99K 50.47% | 206.55K 73.75% | 1.33M 542.31% | 15.79M 1,090.55% | -298.56K 101.89% | -1.25M 317.67% | -2.26M 81.50% | |
net debt to ebitda | 2.14 - | 1.25 41.65% | 0.50 59.74% | 1.02 103.22% | 0.56 45.22% | 0.36 35.40% | 0.19 47.43% | 0.88 359.97% | 0.20 76.86% | 0.35 70.41% | 0.14 58.68% | |
net income per share | -0.06 - | -0.09 53.03% | -0.11 19.87% | -0.03 70.00% | -0.03 11.13% | -0.02 28.81% | -0.04 86.21% | -0.08 89.16% | -0.06 26.14% | -0.02 66.60% | -0.01 20.72% | |
operating cash flow per share | -0.04 - | -0.07 84.04% | -0.08 18.29% | -0.04 46.75% | -0.03 38.55% | -0.02 30.93% | -0.02 27.07% | -0.03 31.94% | -0.04 31.52% | -0.02 56.53% | -0.01 51.29% | |
payables turnover | 0.00 - | |||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -0.98 - | -0.78 19.79% | -2.02 157.30% | -0.85 57.89% | -1.54 81.47% | -1.07 30.61% | -1.55 44.54% | -1.17 24.48% | -3.91 234.71% | -2.50 36.01% | -4.47 78.75% | |
revenue per share | ||||||||||||
roe | -0.99 - | -0.86 13.46% | -4.81 459.93% | -1.00 79.22% | -2.05 104.82% | -1.43 30.35% | -0.57 59.76% | -0.70 22.10% | -1.42 101.82% | -0.59 58.07% | -0.78 30.93% | |
roic | -1.12 - | -0.87 21.82% | -4.88 459.56% | -0.96 80.28% | -2.17 125.30% | -1.40 35.57% | -0.46 67.01% | -0.63 36.11% | -1.34 114.15% | -0.49 63.25% | -0.27 46.02% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 0.06 - | 0.11 76.84% | 0.02 78.59% | 0.03 44.36% | 0.01 56.61% | 0.02 2.20% | 0.07 362.80% | 0.11 54.93% | 0.04 63.40% | 0.03 20.36% | 0.02 39.45% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 1.21M - | 2.29M 89.20% | 539.26K 76.42% | 1.59M 195.68% | 792.62K 50.29% | 960.78K 21.22% | 1.93M 100.78% | 16.31M 745.33% | 102.72K 99.37% | -1.07M 1,142.08% | -2.15M 100.53% | |
tangible book value per share | 0.06 - | 0.11 79.19% | 0.02 79.03% | 0.03 50.28% | 0.01 57.57% | 0.02 5.87% | 0.02 20.17% | 0.06 237.76% | 0.00 99.47% | -0.00 1,081.88% | -0.01 78.86% | |
working capital | 1.20M - | 2.28M 90.19% | 531.80K 76.67% | 1.59M 198.76% | 786.99K 50.47% | 206.55K 73.75% | 1.79M 764.70% | 16.20M 806.87% | -2.21K 100.01% | -1.08M 48,817.56% | -2.18M 101.52% |
All numbers in CAD (except ratios and percentages)